GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 401 - 425 of 4050 in total
Antibody Patient Onset (days) Symptom ▲ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 2 15 mild
G96865DJ
35
IgG Patient 2 15 mild
G96881BQ
24
IgG Patient 2 15 mild
G98068PA
38
IgG Patient 2 15 mild
G98240FC
344
IgG Patient 2 15 mild
G99603GB
14634
IgG Patient 2 24 mild
G00048MO
33
IgG Patient 2 24 mild
G00051MO
24
IgG Patient 2 24 mild
G00052MO
29
IgG Patient 2 24 mild
G00053MO
23
IgG Patient 2 24 mild
G00054MO
23
IgG Patient 2 24 mild
G00057MO
155
IgG Patient 2 24 mild
G00065MO
25
IgG Patient 2 24 mild
G00066MO
210
IgG Patient 2 24 mild
G00068MO
32
IgG Patient 2 24 mild
G02557XE
26
IgG Patient 2 24 mild
G02670IJ
35
IgG Patient 2 24 mild
G03499BP
61
IgG Patient 2 24 mild
G07483YN
30
IgG Patient 2 24 mild
G08340FW
6617
IgG Patient 2 24 mild
G08520NM
37
IgG Patient 2 24 mild
G09482NW
46
IgG Patient 2 24 mild
G09609EN
107
IgG Patient 2 24 mild
G10133VD
97
IgG Patient 2 24 mild
G10789DJ
580
IgG Patient 2 24 mild
G11460AB
99

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024